Lv6
1990 积分 2022-10-25 加入
Preclinical translational physiologically based pharmacokinetic modeling for predicting human pharmacokinetics of proteolysis targeting chimeras: Case studies of vepdegestrant (ARV-471) and bavdegalutamide (ARV-110)
1个月前
已完结
Arvinas’s PROTACs pass first safety and PK analysis
1个月前
已完结
Phase 1 study of HP518, a PROTAC AR degrader in patients with mCRPC: results on safety, pharmacokinetics, and anti-tumor activity
1个月前
已完结
Link between drug absorption solubility and permeability measurements in Caco-2 cells
1个月前
已完结
Preclinical translational physiologically based pharmacokinetic modeling for predicting human pharmacokinetics of proteolysis targeting chimeras: Case studies of vepdegestrant (ARV-471) and bavdegalutamide (ARV-110)
1个月前
已完结
Application of machine learning based methods in exposure–response analysis
2个月前
已完结
Steady‐state pharmacokinetics of indobufen enantiomers in patients with obliterative atherosclerosis
2个月前
已完结
Indobufen
3个月前
已完结
Incidence of thrombocytopenia with gemcitabine-based therapy and influence of dosing and schedule
4个月前
已完结
Mepolizumab in CRSwNP/ECRS and NP: the phase III randomised MERIT trial in Japan, China, and Russia
5个月前
已完结
皖公网安备34019202002308
